The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa
<p><strong>Introduction:</strong> Many HIV-positive individuals in Africa have advanced disease when initiating antiretroviral therapy (ART) so have high risks of opportunistic infections and death. The REALITY trial found that an enhanced-prophylaxis package including fluconazole...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Journal article |
| 語言: | English |
| 出版: |
Wiley
2020
|